Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Post hoc analysis of large Phase 3 (BMT CTN 0702) demonstrates removing urine assessments from IMWG response criteria changed assessments for only 1.1% of patients, and had no appreciable impact on PFS.”
Authors: Rahul Banerjee, Amber Fritz, Othman Akhtar, Edward Stadtmauer, Marcelo Pasquini et al.
More posts featuring Robert Orlowski.
